Clinical Trial Update: Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating durvalumab with consolidation SBRT after chemoradiation for locally advanced stage III non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Brown University | Conditions: Stage III Non-small-cell Lung Cancer | Phase 2 | Status: COMPLETED